Strata Critical Medical (SRTA) Operating Leases (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Operating Leases data on file, last reported at $3.5 million in Q1 2026.

• Quarterly Operating Leases fell 38.99% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 38.99% YoY) and the FY2025 annual result came in at $2.7 million, up 13.66% from the prior year.
• Operating Leases climbed to $3.5 million in Q1 2026 per SRTA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Operating Leases topped out at $23.7 million in Q3 2024 and bottomed at $962000.0 in Q1 2022.
• The 5-year median for Operating Leases is $14.5 million (2022), against an average of $11.7 million.
• The widest annual swing landed in 2022, when Operating Leases soared 5284.89%; it then plunged 88.16% in 2024.
• Tracing SRTA's Operating Leases over 5 years: stood at $15.0 million in 2022, then jumped by 31.85% to $19.7 million in 2023, then sank by 88.16% to $2.3 million in 2024, then gained by 13.66% to $2.7 million in 2025, then jumped by 31.11% to $3.5 million in 2026.
• Per Business Quant, the three latest SRTA Operating Leases figures stand at $3.5 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025).

Peer Comparison